Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · IEX Real-Time Price · USD
7.27
+0.07 (0.97%)
At close: May 17, 2024, 4:00 PM
6.93
-0.34 (-4.68%)
After-hours: May 17, 2024, 5:31 PM EDT
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $355.72 million as of May 17, 2024. Its market cap has decreased by -7.75% in one year.
Market Cap
355.72M
Enterprise Value
172.17M
1-Year Change
-7.75%
Ranking
Category
Stock Price
$7.27
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $355.72M, a decrease of -10.56%. That is a compound annual growth rate of -4.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2024 | 356.70M | -4.01% |
| May 15, 2024 | 371.60M | -0.40% |
| May 14, 2024 | 373.10M | 4.89% |
| May 13, 2024 | 355.70M | -1.79% |
| May 10, 2024 | 362.20M | -3.05% |
| May 9, 2024 | 373.60M | 2.13% |
| May 8, 2024 | 365.80M | -1.35% |
| May 7, 2024 | 370.80M | -2.73% |
| May 6, 2024 | 381.20M | -2.41% |
| May 3, 2024 | 390.60M | 1.56% |
| May 2, 2024 | 384.60M | 1.56% |
| May 1, 2024 | 378.70M | 3.39% |
| Apr 30, 2024 | 366.30M | -1.35% |
| Apr 29, 2024 | 371.30M | 3.89% |
| Apr 26, 2024 | 357.40M | 1.97% |
| Apr 25, 2024 | 350.50M | -0.28% |
| Apr 24, 2024 | 351.50M | -1.65% |
| Apr 23, 2024 | 357.40M | 1.82% |
| Apr 22, 2024 | 351.00M | -1.38% |
| Apr 19, 2024 | 355.90M | 1.83% |
| Apr 18, 2024 | 349.50M | 0.43% |
| Apr 17, 2024 | 348.00M | -3.17% |
| Apr 16, 2024 | 359.40M | -3.85% |
| Apr 15, 2024 | 373.80M | 0.13% |
| Apr 12, 2024 | 373.30M | -2.07% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ModivCare | 381.85M |
| Anavex Life Sciences | 380.04M |
| FibroBiologics | 375.94M |
| Cerus | 375.33M |
| Alto Neuroscience | 372.07M |
| Treace Medical Concepts | 368.95M |
| Solid Biosciences | 366.87M |
| Precigen | 363.48M |